progenity
report
third
quarter
financial
results
provide
corporate
update
san
diego
globe
newswire
progenity
nasdaq
prog
biotechnology
company
established
track
record
success
developing
commercializing
molecular
testing
products
today
announced
report
third
quarter
financial
results
monday
november
close
financial
markets
progenity
management
host
webcast
conference
call
et
pt
day
discuss
financial
results
provide
corporate
update
live
call
may
accessed
dialing
domestic
callers
international
callers
entering
conference
code
live
webcast
archive
call
available
online
investor
relations
section
company
website
progenity
progenity
biotechnology
company
established
track
record
success
developing
commercializing
molecular
testing
products
well
innovating
field
precision
medicine
progenity
provides
vitro
molecular
tests
designed
improve
lives
providing
actionable
information
helps
guide
patients
physicians
making
medical
decisions
key
life
stages
company
applies
approach
combining
genomics
epigenomics
proteomics
metabolomics
molecular
testing
products
development
suite
investigational
ingestible
devices
designed
provide
precise
diagnostic
sampling
drug
delivery
solutions
progenity
vision
transform
healthcare
become
precise
personal
improving
diagnoses
disease
improving
patient
outcomes
localized
treatment
targeted
therapies
additional
information
progenity
please
visit
company
website
investor
contact
robert
uhl
managing
director
westwicke
icr
ir
media
contact
kate
cg
life
kblomlowery
